GL1X · GenesisL1 explorer

Research workbench

Crystal structure of probable short-chain dehydrogenase-reductase from mycobacterium tuberculosis

Analyse Crystal structure of probable short-chain dehydrogenase-reductase from… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3GVC
Type
protein
Length
999 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Probable short-chain type DEHYDROGENASE/REDUCTASE
EC
1.-.-.-
UniProt
P95273
Pockets
13 · best druggability 0.76

Structure

x-ray diffraction · 4 distinct chains · 50% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable short-chain type DEHYDROGENASE/REDUCTASE (EC 1.-.-.-)protein24551% helix, 16% strandP95273
BProbable short-chain type DEHYDROGENASE/REDUCTASE (EC 1.-.-.-)protein25550% helix, 16% strandP95273
CProbable short-chain type DEHYDROGENASE/REDUCTASE (EC 1.-.-.-)protein25049% helix, 17% strandP95273
DProbable short-chain type DEHYDROGENASE/REDUCTASE (EC 1.-.-.-)protein24952% helix, 16% strandP95273

Pockets

13 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13480.760.8651empty
24010.720.8355empty
33190.720.8450empty
42000.620.8332empty
51590.580.8224empty

Interfaces

3 interfaces between chains.

  • C–D · 1458 Ų buried · 19 hydrogen bonds · protein-protein
  • A–B · 1418 Ų buried · 20 hydrogen bonds · protein-protein
  • A–C · 338 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 3GVC · Crystal structure of probable short-chain dehydrogenase-reductase from Mycobacterium… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.